International 2-Day Men’s Health Workshop in Copenhagen

Focus of the Instruction

The training focused on three generations of focused shockwave therapy, ultrasound, diagnostics, ED, Peyronie’s disease, and CPPS. The key point here was to link measurements and imaging to clinical decision-making, so that the technology does not become an end in itself. When I teach, the goal is for participants to be able to explain why a particular treatment is chosen, for whom it is appropriate, and when a different approach is more relevant.

Why this is relevant to a patient’s journey

At Peyronie’s disease and newly developed curvature The clinical assessment is at least as important as the choice of treatment itself. Plaque, calcification, pain, stability, erectile quality, and the degree of curvature should be evaluated as a whole. It is precisely this type of differentiation that makes it possible to explain to the patient what shockwave therapy can and cannot realistically be expected to change. In cases of CP/CPPS and chronic pelvic pain, the patient’s journey is often long because the symptoms can stem from multiple structures and mechanisms simultaneously. The pelvic floor, nerves, connective tissue, pain regulation, urinary symptoms, and sexual activity may all be interrelated. The training therefore supports a broader assessment in which shockwave therapy or EMTT is not used in isolation but is selected based on the clinical picture.

That’s also how I want to work at the clinic: first, understand the problem; then, choose the appropriate tests; and finally, decide whether treatment makes sense. This reduces the risk of starting a standard course of treatment based on insufficient evidence.

From Education to Clinical Quality

International training is not, in and of itself, proof of a treatment’s effectiveness. Its value lies in the professional exposure it provides: questions from other practitioners, comparisons of equipment and protocols, discussions of research, and encounters with other patient populations. This compels me to continually distinguish between what is biologically plausible, what has been clinically observed, and what is actually supported by research.

Another important element is managing expectations. In areas such as sexual function, chronic pain, and incontinence, two patients with the same diagnosis may have vastly different causes and prognoses. Therefore, it is important to be precise about which problem is being addressed, how progress is measured, and when a lack of response should lead to a reassessment rather than simply continuing with the same treatment.

I also emphasize the importance of distinguishing between mechanism, clinical evidence, and marketing. The fact that a technology can biologically affect tissue does not mean that it has a documented effect on all indications. Conversely, clinical evidence may be relevant without being directly transferable between different devices, doses, or patient groups. This distinction is crucial both in teaching and in conversations with patients.

It is the professional connection between education and clinical practice that I want these educational activities to demonstrate: not a promise of results, but experience in critically evaluating technology, following the evidence, and translating it into more precise decisions for each individual patient.

Read more: Men’s Health Workshops for Healthcare Professionals · Diagnosis and Treatment of Erectile Dysfunction

Documentation: This article is based on publicly available event materials and/or LinkedIn posts. Sources: LinkedIn posts